Hsp90 inhibition protects against inherited retinal degeneration

The molecular chaperone Hsp90 is important for the functional maturation of many client proteins, and inhibitors are in clinical trials for multiple indications in cancer. Hsp90 inhibition activates the heat shock response and can improve viability in a cell model of the P23H misfolding mutation in rhodopsin that causes autosomal dominant retinitis pigmentosa (adRP). Here, we show that a single low dose of the Hsp90 inhibitor HSP990 enhanced visual function and delayed photoreceptor degeneration in a P23H transgenic rat model. This was associated with the induction of heat shock protein expression and reduced rhodopsin aggregation. We then investigated the effect of Hsp90 inhibition on a different type of rod opsin mutant, R135L, which is hyperphosphorylated, binds arrestin and disrupts vesicular traffic. Hsp90 inhibition with 17-AAG reduced the intracellular accumulation of R135L and abolished arrestin binding in cells. Hsf-1−/− cells revealed that the effect of 17-AAG on P23H aggregation was dependent on HSF-1, whereas the effect on R135L was HSF-1 independent. Instead, the effect on R135L was mediated by a requirement of Hsp90 for rhodopsin kinase (GRK1) maturation and function. Importantly, Hsp90 inhibition restored R135L rod opsin localization to wild-type (WT) phenotype in vivo in rat retina. Prolonged Hsp90 inhibition with HSP990 in vivo led to a posttranslational reduction in GRK1 and phosphodiesterase (PDE6) protein levels, identifying them as Hsp90 clients. These data suggest that Hsp90 represents a potential therapeutic target for different types of rhodopsin adRP through distinct mechanisms, but also indicate that sustained Hsp90 inhibition might adversely affect visual function.

[1]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[2]  D. Athanasiou,et al.  The cell stress machinery and retinal degeneration , 2013, FEBS letters.

[3]  G. Shapiro,et al.  First-in-Human Phase I Dose-Escalation Study of the HSP90 Inhibitor AUY922 in Patients with Advanced Solid Tumors , 2013, Clinical Cancer Research.

[4]  L. Neckers,et al.  Contributions of co-chaperones and post-translational modifications towards Hsp90 drug sensitivity. , 2013, Future medicinal chemistry.

[5]  Vadim Y Arshavsky,et al.  Proteasome overload is a common stress factor in multiple forms of inherited retinal degeneration , 2013, Proceedings of the National Academy of Sciences.

[6]  C. Jao,et al.  Visual arrestin interaction with clathrin adaptor AP-2 regulates photoreceptor survival in the vertebrate retina , 2013, Proceedings of the National Academy of Sciences.

[7]  J. Buchner,et al.  Structure, Function and Regulation of the Hsp90 Machinery , 2013, Biomedical journal.

[8]  D. Athanasiou,et al.  BiP prevents rod opsin aggregation , 2012, Molecular biology of the cell.

[9]  G. Bates,et al.  Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease. , 2011, The Journal of clinical investigation.

[10]  I. Pinilla,et al.  Tauroursodeoxycholic acid prevents retinal degeneration in transgenic P23H rats. , 2011, Investigative ophthalmology & visual science.

[11]  U. Kompella,et al.  Rescue of Photoreceptor Degeneration by Curcumin in Transgenic Rats with P23H Rhodopsin Mutation , 2011, PloS one.

[12]  P. Workman,et al.  A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors , 2011, Clinical Cancer Research.

[13]  P. Humphries,et al.  Prevention of autosomal dominant retinitis pigmentosa by systemic drug therapy targeting heat shock protein 90 (Hsp90). , 2010, Human molecular genetics.

[14]  S. Lindquist,et al.  HSP90 at the hub of protein homeostasis: emerging mechanistic insights , 2010, Nature Reviews Molecular Cell Biology.

[15]  W. Hauswirth,et al.  Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78 , 2010, Proceedings of the National Academy of Sciences.

[16]  O. L. Moritz,et al.  The Role of Rhodopsin Glycosylation in Protein Folding, Trafficking, and Light-Sensitive Retinal Degeneration , 2009, The Journal of Neuroscience.

[17]  M. Cheetham,et al.  Calnexin is not essential for mammalian rod opsin biogenesis , 2008, Molecular vision.

[18]  M. Lavail,et al.  The relationship of photoreceptor degeneration to retinal vascular development and loss in mutant rhodopsin transgenic and RCS rats. , 2008, Experimental eye research.

[19]  M. Cheetham,et al.  Pharmacological manipulation of gain-of-function and dominant-negative mechanisms in rhodopsin retinitis pigmentosa. , 2008, Human molecular genetics.

[20]  M. Cheetham,et al.  The Leber congenital amaurosis protein AIPL1 functions as part of a chaperone heterocomplex. , 2008, Investigative ophthalmology & visual science.

[21]  L. Pearl,et al.  The Hsp90 molecular chaperone: an open and shut case for treatment. , 2008, The Biochemical journal.

[22]  Chao Zhang,et al.  IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response , 2007, Science.

[23]  T. Salt,et al.  Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction , 2007, Proceedings of the National Academy of Sciences.

[24]  A. K. Mandal,et al.  Molecular chaperones and protein kinase quality control. , 2007, Trends in cell biology.

[25]  C. Cepko,et al.  Controlled expression of transgenes introduced by in vivo electroporation , 2007, Proceedings of the National Academy of Sciences.

[26]  J. Klein-Seetharaman,et al.  Retinitis pigmentosa associated with rhodopsin mutations: Correlation between phenotypic variability and molecular effects , 2006, Vision Research.

[27]  D. Oprian,et al.  Stable Rhodopsin/Arrestin Complex Leads to Retinal Degeneration in a Transgenic Mouse Model of Autosomal Dominant Retinitis Pigmentosa , 2006, The Journal of Neuroscience.

[28]  G. Sobue,et al.  Alleviating Neurodegeneration by an Anticancer Agent , 2006, Annals of the New York Academy of Sciences.

[29]  M. Cheetham,et al.  Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy. , 2005, Trends in molecular medicine.

[30]  J. Hurley,et al.  Leber congenital amaurosis linked to AIPL1: a mouse model reveals destabilization of cGMP phosphodiesterase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Fain,et al.  AIPL1, the protein that is defective in Leber congenital amaurosis, is essential for the biosynthesis of retinal rod cGMP phosphodiesterase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Sung,et al.  Structural and functional impairment of endocytic pathways by retinitis pigmentosa mutant rhodopsin-arrestin complexes. , 2004, The Journal of clinical investigation.

[33]  S. Kaushal,et al.  Retinoids Assist the Cellular Folding of the Autosomal Dominant Retinitis Pigmentosa Opsin Mutant P23H* , 2004, Journal of Biological Chemistry.

[34]  J. Benovic,et al.  G Protein-coupled Receptor Kinase Interaction with Hsp90 Mediates Kinase Maturation* , 2003, Journal of Biological Chemistry.

[35]  Russell G Foster,et al.  Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. , 2003, Nucleic acids research.

[36]  Peter M. G. Munro,et al.  The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation. , 2002, Journal of cell science.

[37]  H. Lehrach,et al.  Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease. , 2001, Human molecular genetics.

[38]  P. Dolph,et al.  The Formation of Stable Rhodopsin-Arrestin Complexes Induces Apoptosis and Photoreceptor Cell Degeneration , 2000, Neuron.

[39]  C. Cepko,et al.  Mutations in a new photoreceptor-pineal gene on 17p cause Leber congenital amaurosis , 2000, Nature Genetics.

[40]  R. Voellmy,et al.  Repression of Heat Shock Transcription Factor HSF1 Activation by HSP90 (HSP90 Complex) that Forms a Stress-Sensitive Complex with HSF1 , 1998, Cell.

[41]  D. Raman,et al.  Rhodopsin arginine-135 mutants are phosphorylated by rhodopsin kinase and bind arrestin in the absence of 11-cis-retinal. , 1998, Biochemistry.

[42]  Ivor J. Benjamin,et al.  Targeted Disruption of Heat Shock Transcription Factor 1 Abolishes Thermotolerance and Protection against Heat-inducible Apoptosis* , 1998, The Journal of Biological Chemistry.

[43]  K. Palczewski,et al.  Activation and inactivation steps in the visual transduction pathway , 1997, Current Opinion in Neurobiology.

[44]  T. Dryja,et al.  Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness , 1997, Nature Genetics.

[45]  M. Tamai,et al.  A homozygous 1–base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese , 1995, Nature Genetics.

[46]  David W. Yandell,et al.  A point mutation of the rhodopsin gene in one form of retinitis pigmentosa , 1990, Nature.

[47]  G. Giaccone,et al.  Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies. , 2010, European journal of cancer.

[48]  C. Cepko,et al.  Analysis of gene function in the retina. , 2008, Methods in molecular biology.

[49]  S. Liebowitz.  Retinitis pigmentosa. , 1979, Journal - American Intra-Ocular Implant Society.